Standard Biotools Inc.
LABNasdaqCIK 1162194HealthcareFiscal year ends Dec 31
Reports and events: 343 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-0520:16 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-038624 |
| 2026-09-3021:27 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-038110 |
| 2026-08-0520:10 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-335103 |
| 2026-08-0520:10 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-335106 |
| 2026-07-2912:15 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001140361-26-029964 |
| 2026-07-2812:20 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-029841 |
| 2026-07-2420:38 ET | 8-K | 3.01 Delisting notice | 0001193125-26-316183 |
| 2026-06-1820:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-275946 |
| 2026-06-1221:35 ET | SCHEDULE 13D | Ownership report, active investor | 0000905148-26-002940 |
| 2026-06-0921:41 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000919574-26-003923 |
| 2026-06-0812:31 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-071195 |
| 2026-06-0521:01 ET | 8-K | 8.01 Other events | 0001193125-26-259877 |
| 2026-06-0320:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-255403 |
| 2026-05-2820:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-245181 |
| 2026-05-0620:10 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-208967 |
| 2026-05-0520:10 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-206395 |
| 2026-04-2720:15 ET | DEF 14A | Proxy statementPeriod 2026-06-17 | 0001140361-26-017100 |
| 2026-04-2420:15 ET | 8-K | 3.01 Delisting notice | 0001193125-26-177290 |
| 2026-03-1620:05 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-108326 |
| 2026-02-2421:15 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-067026 |
| 2026-02-0521:38 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001104659-26-010965 |
| 2026-01-3014:18 ET | 8-K | 2.01 Completion of an acquisition or disposition; 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-008375 |
| 2026-01-0812:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-006996 |
| 2025-11-2822:33 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000919574-25-007210 |
| 2025-11-0421:11 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-264695 |
| 2025-11-0421:10 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-264693 |
| 2025-09-1720:05 ET | 8-K | 2.05 Exit or disposal costs | 0001193125-25-206150 |
| 2025-09-0310:05 ET | 8-K | 2.05 Exit or disposal costs | 0000950170-25-112662 |
| 2025-08-1520:05 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-109388 |
| 2025-08-1121:00 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-106636 |
| 2025-08-0120:20 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-25-101439 |
| 2025-06-2313:11 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-061438 |
| 2025-06-2020:16 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-25-088519 |
| 2025-05-0621:05 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-064606 |
| 2025-05-0620:05 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-064439 |
| 2025-04-3011:21 ET | DEF 14A | Proxy statementPeriod 2025-06-18 | 0001140361-25-016515 |
| 2025-03-1122:20 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-036608 |
| 2025-03-0400:46 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000919574-25-001773 |
| 2025-02-2621:05 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-027712 |
| 2025-01-1312:08 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-002848 |
| 2025-01-1021:09 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-25-004155 |
| 2024-12-2021:14 ET | 8-K | 9.01 Financial statements and exhibits | 0000950170-24-139051 |
| 2024-11-0713:06 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-24-122823 |
| 2024-11-0622:17 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-122473 |
| 2024-10-3020:17 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-119014 |
| 2024-09-0520:07 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-097368 |
| 2024-08-3020:08 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-24-095596 |
| 2024-08-1400:54 ET | SC 13D/A | Ownership report, active investor, amended | 0000919574-24-004765 |
| 2024-08-0620:30 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-091888 |
| 2024-07-3120:20 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-24-084362 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:05 ET. Listed shows no prices and gives no investment advice.